KIAA0087

Across TCGA pan-cancer cohorts, KIAA0087 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated KIAA0087 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher KIAA0087 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated KIAA0087 expression acts as an unfavorable survival marker, although some lineages such as PDAC and LSCC show a favorable association.

PDAC, LSCC, and CCRCC are the cancer types where KIAA0087 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Tertile	III,IV	0.938	0.300	.020	4	view →
LSCC	OS	Median	All	1.000	0.793	.031	4	view →
CCRCC	OS	Median	II,III,IV	1.000	0.401	.024	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

KIAA0087–PDAC (OS)

Open the PDAC breakdown →